希氏束-浦肯野系统起搏在心脏再同步化治疗中作用研究的进展  

Research progress of effect of His-purkinje system pacing in cardiac resynchronization therapy

作　　者：赵珍莉 栾颖[1] ZHAO Zhen-li;LUAN Ying(Department of Cardiology,Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150081,China)

机构地区：[1]哈尔滨医科大学附属第二医院心内科,黑龙江哈尔滨150081

出　　处：《心血管康复医学杂志》2021年第4期499-502,共4页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：心脏再同步化治疗(CRT)是治疗充血性心力衰竭(CHF)的有效器械方法。传统CRT通过双心室起搏(BVP)提高CHF患者生活质量和运动耐量,降低住院率及全因死亡率,但BVP仍存在一些局限性。近年来研究发现希氏束-浦肯野系统起搏因符合生理性起搏的优势,有可能替代传统CRT。本文就希氏束-浦肯野系统起搏在CRT中作用研究的进展作一综述。Cardiac resynchronization therapy(CRT)is an effective mechanical method for treatment of congestive heart failure(CHF).Traditional CRT improves quality of life and exercise tolerance,reduces hospitalization rate and all-cause mortality in CHF patients by biventricular pacing(BVP).However,BVP possesses some limitations.In recent years,researchers have found that His-purkinje system pacing possesses the possibility of replacing the traditional CRT,because of compliance with physiological pacing.The present article makes a review on research progress of His-purkinje system pacing in CRT.

关 键 词：心力衰竭 心脏再同步疗法 希氏束 

分 类 号：R541.6[医药卫生—心血管疾病]